Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv for ADHD-Associated Insomnia
NCT01156051Phase 4Terminated
- Sponsor
- Children's Specialized Hospital
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of guanfacine in attention deficit hyperactivity disorder (ADHD) and Insomnia, sponsored by Children's Specialized Hospital. Primary endpoint: Polysomnographic Total Sleep Time at 5 weeks. Started Jun 2010; status: terminated.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)Insomnia
Beyond the preview
Go deeper on NCT01156051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156051.